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Tristetraprolin in Human Periodontal Health and Disease
Abstract
Background: Tristetraprolin (TTP) is an RNA binding protein that tightly regulates target
mRNA stability and translation through specific interactions with AU-rich regions of target
mRNA 3’ untranslated region (UTR). TTP has been shown to play an important role involving
decreased translation of important inflammatory cytokines in periodontal disease including TNFa, IL-6 and other immune mediators. The role of TTP was initially demonstrated in TTP knockout mice that displayed systemic inflammatory conditions, including rheumatoid arthritis and
dermatitis. The p38 MAPK cascade that is activated by bacterial-derived lipopolysaccharide
(LPS) has been demonstrated to be part of the deactivation process of TTP. MAPK-activated
protein kinase-2 (MK2), the immediate downstream kinase of p38 MAPK, directly deactivates
TTP through phosphorylation, which allows increased mRNA stability and translation of target
inflammatory mediators. Our goal of this study was to determine the amount of expression of
proteins MK2, phosphor-MK2 (pMK2, the active form), and total TTP in human gingival tissues
in health and disease.
Materials and Methods: Human gingival tissues samples were collected from twenty-five
periodontally healthy (control group) and twenty-five periodontal disease subjects (test group) in
addition to clinical measurements. In order to test a true representation of periodontal health and
disease, samples were removed due to clinical confounding factors and insufficient size tissues.
Remaining samples were stained with hematoxylin and eosin (H&E) for histopathological
analysis. Additionally, immunohistochemistry (IHC) staining was performed with specific
antibodies against MK2, pMK2, and TTP. H&E inflammatory infiltrate scores, IHC intensity for
all three proteins of interest, and IHC area scores were assigned to each sample by a blinded
pathologist. Statistical analysis with Spearman Rank Correlation and Fisher’s Exact Test were
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performed to determine the relationship between the expression of the proteins and inflammatory
scores and clinical measurements. Clinical measurements were represented by the periodontal
inflammatory burden index (PIBI).
Results: Mean values for all scores were higher for the test group compared to the control group.
MK2 and TTP intensity, area, and composite scores had a statistically significant positive
correlation to both H&E scores and PIBI shown from the results of the Spearman Rank
Correlation. Intensity and composite scores for pMK2 also showed a positive correlation that was
statistically significant. The area scores for pMK2 showed a significant relationship to H&E
scores but not to PIBI. Findings from the Fisher Exact test stated that the H&E scores and all IHC
values except for the pMK2 area score showed high predictability for periodontal disease status.
Conclusion: There is an increased expression of MK2, pMK2, and TTP in periodontally diseased
tissues when compared to the healthy samples. All three proteins showed a strong, positive
correlation to inflammation and periodontal disease. The current TTP findings contrasted those
found in previous studies, which can be explained by indiscriminate binding of the TTP antibody
to all forms of TTP. Further investigations are necessary to understand the extent of TTP’s role in
periodontitis and its potential as a target in treating periodontal disease.

viii

Chapter One
Tristetraprolin in Human Periodontal Health and Disease
Introduction
The periodontium consists of several key components that primarily serve as the support
mechanism for the tooth, that includes the cementum, periodontal ligament, alveolar bone, and
dentogingival junction. The dentogingival junction consists of connective tissue fiber attachment
and junctional epithelium.
The junctional epithelium consists of undifferentiated, stratified squamous epithelium
with the approximate width of 20-30 cells1 and contains a basal lamina-like structure on the tooth
and connective tissue interfaces. These two structures converge apically to define the separation
between the junctional epithelium and the connective tissue attachment. The epithelial attachment
of the junctional epithelium to the tooth is by hemidesmosomes.2 The junctional epithelium has
been described to be 0.97 mm in an coronal to apical direction although this measurement has a
large amount of variability.3 Additionally, the junctional epithelium contains polymorphonuclear
leukocytes and monocytes as one of the first lines of defense against bacterial infection.
Directly apical to the junctional epithelium is the connective tissue attachment. There are
several connective tissue fiber attachments that are associated with the periodontium. Three
connective tissue fibers have attachment to the cementum including dentogingival,
dentoperiosteal and transseptal fibers. These fibers provide support to the tooth and the structure
of the gingiva. This attachment has been shown to be the most consistent across individuals and
teeth at 1.07 mm distance in the coronal to apical direction.3
The cementum is the tooth-borne surface of the periodontium and provides an attachment
structure for the periodontal ligaments. Cementum is comprised of 50% hydroxyapatite and 50%
collagenous and non-collagenous proteins with type I collagen being the most abundant. It is
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avascular and is not innervated.4 Based on the presence of cementocytes, cementum can be
divided into cellular and acellular cementum. Additionally, cementum can be classified as
intrinsic or extrinsic based on the origin of the collagen by cementoblasts or fibroblasts,
respectively. The four classifications of cementum are acellular afibrillar, cellular intrinsic,
cellular stratified mixed, or acellular extrinsic. These are divided based on location and function.
Acellular afibrillar cementum is located at the cementoenamel junction and has no function after
initial eruption. Cellular intrinsic cementum contains cementocytes and have fibers that are
parallel to the surface of the root. Cellular stratified mixed cementum is usually found in the
apical one third of the root and in the furcation areas in multi-rooted teeth. This cementum has
alternating layers of acellular extrinsic and cellular intrinsic cementum. The majority of
cementum is acellular extrinsic cementum. This type of cementum covers about 40-70% of the
root surface and anchors the tooth to the bone by the periodontal ligament.5
The periodontal ligament has a primary function of suspension of the tooth in the alveolar
socket. Secondary functions include providing vasculature, innervation, and providing a source of
pluripotent cells. The width of the PDL is 0.15 to 0.38 mm and composed mostly of collagen.
Sharpey’s fibers are collagenous structures that enter into the cementum and the bone consisting
of type I collagen. Fibroblasts, sensory cells, osteogenic cells, osteoclasts, and osteoblasts are
present in the periodontal ligament space.6 Isolated periodontal ligament cells have also been
shown to have mesenchymal stem cell properties.7

Diagnosis of Periodontal Disease
Diagnosis of periodontal disease begins with a comprehensive periodontal exam. This
examination is an extensive review of extraoral and intraoral structures. The intraoral exam as it
pertains the periodontium involves periodontal probing, assessment of bleeding on probing,
plaque scoring, assessment of mobility, and measurements of furcation involvement. Although
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there is variability with probing force and examiner experience, there is a 90% agreement
between measurements within 1mm.8 There can be differences to the depth of probing. Studies
have showed that there is variability in the extent to which the tip of the probe penetrates tissues
in an apical direction. The periodontal probe has been shown to extend to the apical portion of the
junctional epithelium9 and even farther into the connective tissue attachment in inflamed tissues.10
Measurements of probing depths and recession are also used to calculate the clinical attachment
level (CAL). Bleeding on probing (BOP) has been used as an indicator of inflammation in the
tissues. However, variables such as smoking, medications, probing force and technique can alter
the amount of bleeding a patient may demonstrate. Smoking is well documented as reducing the
amount of BOP compared to non-smokers.11-13 In addition, medications such as aspirin can
increase the incidence of bleeding upon probing.14 Similarly, a study has showed that the absence
of BOP is a better indicator of health compared to bleeding being an indicator for periodontal
disease.15,16 Probing depths in combination with bleeding on probing, radiographs and clinical
judgement are used to determine appropriate treatment.
A clinician also must assess a patient’s oral hygiene to ensure that the patient will have
the ability to maintain gingival health. The Plaque Index (PI) is an ordinal scale that indicates
severity of plaque with ‘0’ being no plaque, ‘1’ being plaque that requires detection with a probe
at the gingival margin, ‘2’ being plaque visible to the naked eye, and ‘3’ being an excess of
plaque accumulation.17 In addition, an overall plaque score can be assigned based on the
percentage of sites with plaque present.18 The Gingival Index (GI) and Periodontal Inflammatory
Burden Index (PIBI) are more commonly used for research purposes to study inflammation. The
Gingival Index is also an ordinal scale with ‘0’ being normal gingiva, ‘1’ being mild
inflammation with no bleeding on probing, ‘2’ being moderate inflammation with bleeding on
probing, and ‘3’ being severe inflammation with spontaneous bleeding.17 The periodontal
inflammatory burden index has also been created to relate clinical measurements with laboratory
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measurements on a molecular level. The PIBI involves a combination of probing depths to assign
a score to an individual tooth. PIBI is scored based on the number of 4 or 5mm probing depths
plus twice the number of probing depths that are 6mm or greater. Similarly, clinical attachment
level index (CALI) is scored based on CAL measurements of 4 or 5mm plus twice the number of
CAL measurements 6mm or greater. Scores for both PIBI and CALI can range from 0-12 with
the higher values indicative of more severe disease at the individual tooth.19,20
Gingivitis is defined as inflammation of the periodontium without the loss of attachment.
In conjunction with histologic findings, it was found that gingivitis developed in 10 to 21 days
after ceasing oral hygiene. It was also shown that damage incurred during gingivitis was
reversible.21 Gingivitis is diagnosed based on the presence of BOP with an intact periodontal
attachment. It has been described histologically as an initial or early periodontal lesion. The initial
lesion showed the presence of leukocytes in the connective tissue with two to four days of plaque
accumulation. The early lesion represented uninhibited plaque accumulation of four to seven days
and resulted in lymphoid cell aggregation adjacent to the junctional epithelium with increasing
collagen destruction.22 In one study on adults, it was shown that the average GI score of patients
was 1.05. Among all the subjects, 55.7% having a score of greater or equal to 1.00.23 Gingivitis is
a very common occurrence and can be treated very conservatively with prophylaxis and improved
personal oral hygiene.
Periodontitis is differentiated from gingivitis by the loss of alveolar bone. Severity of
periodontitis was defined as clinical attachment loss of 1 or 2mm for slight periodontitis, 3 or 4
mm clinical attachment loss for moderate periodontitis, and 5mm or greater clinical attachment
loss for severe periodontitis.24 Recently, the 2015 AAP Task Force has determined guidelines for
periodontal diseases and severity of periodontitis.25 Health is defined as a site with no BOP while
gingivitis is diagnosed with a PD of 3mm or less with BOP. With all cases of periodontitis, there
is BOP present. Slight periodontitis has a PD of 4mm or clinical attachment loss of 1 to 2mm.
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The diagnosis of moderate periodontitis is determined with a PD of 5 or 6mm or clinical
attachment loss of 3 to 4 mm while severe periodontitis has a PD of 7mm or greater or clinical
attachment loss of 5mm or greater. Evaluation of mobility and furcation involvement play a
substantial role in the treatment decisions of a clinician. A combination of the clinical evaluation,
radiographs, and past records are used to determine a diagnosis and treatment of periodontitis.
Periodontitis results in irreversible damage to the periodontium. With plaque accumulation of two
to three weeks, there is an established lesion that shows a shift from leukocytes to plasma cells
with increasing destruction of collagen. This progresses to pocketing, ulceration, suppuration, and
bone loss.22 The prevalence of periodontitis has been reported as 46% in adults with 8.9% of
adults having severe periodontitis.26 There is a large range of treatment modalities that have
shown to be successful in reducing pocket depths including scaling and root planing, open flap
debridement, osseous surgery, and guided tissue regeneration. All treatments have shown success
in reducing probing depths to treat periodontal disease.27-31 It is necessary to treat the etiology of
periodontal conditions to arrest the disease process. In addition, it is also important for the patient
to understand this information to control his or her plaque through adequate oral hygiene to
maintain a healthy state. Regular recalls are also important for the retention of reduced
periodontal pockets and gingival health. It is well documented that patients that do not pursue or
continue maintenance therapy have worse long term results.32-34 Conversely, continued supportive
therapy has been shown to maintain probing depths at levels seen after surgery even in patients
with less than optimal oral hygiene.35,36 Nonetheless, there is a clear understanding that control of
bacterial plaque is a key component in preventing periodontal disease although the microbiologic
mechanism is not well understood.
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Etiology of Periodontal Disease
There are over 300 bacterial inhabitants in oral plaque37 and over 500 kinds of bacteria in
the periodontal pocket.38 In addition, there is the presence of viruses, Archaea, and fungal
species.39-41 Historically, it was determined that certain bacteria played compartmental, specific
roles in the colonization of the root surface and the periodontal pocket. The yellow complex,
containing mostly of gram positive Streptococcus species, were present in supragingival plaque.
The orange complex was considered the “bridging” group of bacteria and attached to the species
of the yellow complex. The orange complex is described as the connection between the early
colonizing bacteria and the more virulent, pathogenic bacteria. This complex contains several
species but is highlighted by Fusobacterium nucleatum. Lastly, the red complex is considered to
be the most virulent and contains three bacterial species: Poryphyromonas gingivalis, Treponema
denticola, and Tannerella forsythia.42 All three have been found to be elevated in periodontal
pockets and have virulence factors that can contribute to periodontal disease. P. gingivalis is a
gram-negative bacterium. P. gingivalis is potentially different from other gram-negative bacteria
though by different engagement of toll-like receptors and the ensuing host response. This altered
phenotype of LPS in P. gingivalis allows for evasion of the host response and infiltration into
host cells.43 In addition, P. gingivalis has the ability to adhere and invade human epithelial cells in
vitro.44,45 T. denticola is a spirochete that is often found in diseased periodontal pockets. Like P.
gingivalis, T. denticola has factors, such as a major outer sheath protein, that allow it to adhere to
the host tissue and subsequently penetrate into the tissues as well as disrupt fibroblasts and
subsequent collagen formation.46,47 This spirochete has the ability to alter the host response by
activation of innate immunity, upregulation of pro-inflammatory cytokine release, and
suppression of blood mononuclear cells.48,49 Lastly, T. forsythia has virulence mechanisms
including cell adherence and invasion, enzyme proteolysis, and pro-inflammatory cytokine
activation.50-52
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Recently, there has been a shift in the theory regarding the plaque biofilm and the
subgingival environment. This polymicrobial synergy and dysbiosis (PSD) theory involves a
community of bacteria that works and transforms together as opposed to the sole virulence of the
red complex periodontal pathogens. The definition of a polymicrobial synergy is the ability of
bacteria to increase their pathogenicity in the presence of other bacteria. This theory states that
bacteria within the biofilm aid each other in metabolism of products into substrates useful to other
nearby bacteria. The biofilm involves attachment of bacteria to each other and interbacterial
communication. Of the 500 bacteria in present in a diseased periodontal pocket, P. gingivalis is
considered a “keystone” pathogen in this model and orchestrates many processes that allow other
bacteria to thrive and have their effects imposed on the host tissues.53,54 P. gingivalis has been
shown to interact with commensal bacteria including Streptococcus gordonii and Fusobacterium
nucleatum. With S. gordonii, P. gingvalis creates more alveolar bone loss in combination rather
than with either species alone. This study offers proof that commensal bacteria of the Socransky
yellow complex, previously understood to not damage the gingival tissue, can exhibit harmful
effects in combination with other bacteria such as P. gingivalis.55 In addition, P. gingivalis
exhibits virulence factors such as gingival epithelial invasion and to inhibit the inflammatory
response by downregulating Toll-like receptor 4 activity. The host modulation by P. gingivalis
can allow for certain types of bacteria to express their pathogenicity on the host tissues. These
examples bolster the theory that hundreds of bacteria are present in the subgingival biofilm and
with host modulations through specific pathogens, the transformation into a dysbiotic biofilm
occurs. This theory states that important requirements must be satisfied for the pathogenic
bacterial biofilm to activate. The biofilm requires necessary adhesive molecules for the
development of a community comprised of a variety of bacteria. Each bacteria must be
compatible with other bacteria in the community, and there needs to be the ability to resist host
immunity through a combination of the bacteria.53
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Immune System and Periodontal Disease
Bacteria clearly have an influence on the induction of periodontal disease as the mediator
between the oral cavity and the subepithelial tissues. However, it is understood that bacteria do
not directly induce osteoclastogenesis. Osteoclastogenesis and subsequent bone loss is the
defining hallmark of periodontitis, which is a result of signaling through the host’s immune
system. The immune response is divided into two branches: innate and adaptive immunity. Both
play a significant role in the induction and progression of periodontal disease.
Innate immunity is the body’s initial non-specific response to a foreign antigen. The role
of the innate immune system is phagocytic removal of microbial organisms and foreign bodies.
The innate immune response includes recruitment of neutrophils and macrophages as well as
activation of the complement system. Neutrophils and macrophages recognize pathogens through
cell membrane bound pathogen recognition receptors (PRRs), which include the family of Tolllike receptors (TLRs).56 Toll-like receptors recognize microbial-associated molecular patterns
(MAMPs) such as gram-negative bound LPS.57 Recognition of MAMPs induces a cascade of
intracellular processes that results in expression and formation of inflammatory cytokines and
chemokines.58 Another non-specific recognition system is the complement system. It involves an
aggregation of molecules that lead to disruption of bacterial membranes and act as chemokines
for attraction of neutrophils, monocytes, and lymphocytes.59-61
The other arm of the immune system is the adaptive immune response. Adaptive
immunity is the host’s response to a specific pathogen or antigen and the main cells involved are
B- and T-lymphocytes, which are considered to be the main factors in humoral immunity and
cell-mediated immunity, respectively. Pathogens are recognized and require processing to
activate the adaptive immune response. Lymphocytes, macrophages, and dendritic cells are
antigen presenting cells that degrade the pathogen and display a representative antigen. B- and T-
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lymphocytes have receptors that recognize the antigen and respond to mount a defense against the
specific molecule. After recognition of the antigen fragment, B lymphocytes produce antibodies
specific to the antigen. T-lymphocytes are divided into CD4 and CD8 subsets based on the
extracellular expression. The CD4 subset is further divided into T-helper 1 (TH-1) and T-helper 2
(TH-2) cells and are differentiated by their cytokine production. TH-1 cells release interleukin-1
and interferon-g while TH-2 cells secrete interleukins 4, 5, 6, 10, and 13. TH-1 cells have a more
stimulatory response on cells while TH-2 cells tend to have an antagonistic action on cells. Thelper 17 cells and T-regulatory T-cells have also been recently described. TH-17 cells produce
interleukin-17 which plays a role in the facilitating induction of osteoclastogenesis.62,63 On the
other hand, T-regulatory cells have been shown to have a protective effect on the periodontal
tissues and control the activation of other T cells. The cytokines T-regulatory cells produce are
transforming growth factor beta (TGF-b) and T-lymphocyte-associated molecule-4, which
downregulate the inflammatory response.64
The activation of innate and adaptive immunity creates a cascade of events that
intensifies cytokine production. Increase in expression of specific cytokines leads to soft and hard
tissue destruction. Soft tissue destruction is most commonly accomplished through the production
of extracellular degradation enzymes. The most studied family of enzymes in periodontitis is the
matrix metalloproteinases (MMPs), specifically MMP-1, -2, -8, and -9.65 MMP-1 is a collagenase
that destroys interstitial collagen and is secreted by phagocytes, epithelial cells and fibroblasts.
MMP-2 is a gelatinase that is found to be present in epithelial cells of the periodontal pocket
during inflammation. The most significant collagenase in periodontitis is MMP-8. This enzyme is
produced by neutrophils and its substrate is interstitial collagen. There have been numerous
studies showing the increase in MMP-8 in gingival crevicular fluid and saliva in patients with
periodontitis.66-68 MMP-9 is also a gelatinase and is produced by neutrophils.69
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The breakdown of collagen and the extracellular matrix has been described in periodontitis as a
sign of progression from gingivitis to periodontitis. As stated earlier, periodontitis differs from
gingivitis by the presence of alveolar bone loss.
The homeostasis between osteoclasts and osteoblasts is extremely important to maintain
bone. An imbalance between these two cells would cause loss or overgrowth of bone. There are
three major players in the control of osteoclastogenesis: receptor activator of nuclear factor
kappa-B ligand (RANKL), receptor activator of nuclear factor of nuclear factor kappa-B (RANK)
and osteoprotegrin (OPG). RANK is expressed on the surface of osteoclast precursors,
macrophages and dendritic cells. RANKL is secreted by stromal cells, osteoblasts, and other
cells. In the periodontium, osteoprotegrin is expressed by periodontal fibroblasts and periodontal
ligament cells. Binding of RANKL to RANK begins the process of maturation from a preosteoclast to a mature, activated osteoclast, which leads to degradation of bone. OPG acts as a
decoy receptor for RANKL. By binding to RANKL, OPG reduces the amount of RANKL
available to bind to RANK.70 OPG can be described as protective of the bone and has been shown
to inhibit alveolar bone loss in periodontal disease.63 OPG levels were reported to be at a lower
level in periodontal disease compared to health.71 Another important cytokine is the macrophage
colony-stimulating factor (M-CSF) which is secreted by osteoblasts and induces differentiation of
mesenchymal cells into osteoclasts.64 LPS binding to TLR receptors upregulates the production of
inflammatory cytokines IL-1B, TNF-a, and IL-6 to increase the production of RANKL while
decreasing the production of OPG. TNF-a also increases the secretion of M-CSF which allows
for more osteoclast precursors present for RANKL binding maturation.

Immune Modulator Biology
As previously discussed, TLRs are the first receptors in detection of non-host antigens
and are classified under a family of extracellular transmembrane receptors called pattern
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recognition receptors (PRRs). In periodontitis, the most studied TLRs are TLR2 and TLR4.47,72-74
When either of these receptors is activated by a MAMP, there is a recruitment of proteins that
bind to the intracellular component of the TLR receptor. Myeloid differentiation primaryresponse protein 88 (MYD88) is one of these adaptor proteins that is associated with all TLRs
except TLR3. MYD88 interacts with a variety of proteins which begin a cascade of inflammatory
cytokine production. These processes are mediated through upregulation and activation of
mitogen-activated protein kinases (MAPK) and nuclear factor-kb (NF-kb). MAPKs are a large
family of protein kinases that are activated through phosphorylation, and they regulate a large
number of cellular responses including but not limited to inflammation.75 NF-kb functions as a
DNA transcriptional regulator and mainly functions within the nucleus. Both processes result in
an increase in inflammatory cytokines through expression of inflammatory modulator gene
transcription such as IL-1b, TNF-a, Prostaglandin E2 (PGE2), MMP-2, and MMP9.72
In periodontal tissues, IL-1b is a cytokine that is mainly expressed by dendritic cells,
macrophages, and gingival fibroblasts.64 IL-1b is more concentrated in gingival crevicular fluid in
the presence of periodontal disease compared to health.76 It is also a stimulator for the production
of MMPs by fibroblasts and periodontal ligament (PDL) cells.65 IL-1b is also a inducer of bone
resorption and osteoclastogenesis through a few different mechanisms. It stimulates expression of
RANKL by osteoblasts and upregulates production of PGE2 which also enhances RANKL
expression. TNF-a has similar pro-inflammatory actions like IL-1b. TNF-a is produced by
several cells in the periodontium including fibroblasts, PDL cells, monocytes, and osteoblasts.
Like IL-1b, presence of TNF-a is greater in sites with periodontal disease compared to health.77
TNF-a increases the production of MMPs, such as MMP-2 and -9, resulting in collagen
destruction and also increases differentiation into osteoclasts in the presence of macrophage
colony stimulating factor (M-CSF).78 Cytokines that are involved in periodontal disease are not
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limited to these few modulators. There are other inflammatory cytokines in the interleukin family
including more recently discovered IL-17.62 The immunomodulator response in periodontal
disease is very complex and cytokines are often intertwining regulators of each other.

Tristetraprolin Biological Function and Regulation
Tristetraprolin (TTP) is a protein that was discovered in a hybridization study in human
insulin-stimulated cells.79 The effects of TTP were characterized in TTP-knockout mice, which
exhibited a generalized inflammatory condition mostly from the uninhibited production of TNFa.80 TTP is an RNA-binding protein that targets the AU-rich elements (AREs) of the 3’
untranslated target mRNAs. AREs are a sequence of nucleotides that promote rapid decay of
mRNA. TTP belongs to a family of proteins that contain cysteine-cysteine-cysteine-histidine
(CCCH) Zinc fingers. TTP contains two of these zinc fingers with each containing three repeats
of PPPP-motifs. The approximate molecular weight of TTP is 36kDa.81 Through analysis with
microarray, there was stabilization of 250 mRNAs in the absence of TTP with 23 of these
showing two or more conserved TTP binding sites.82 There have been studies that link TTP to
inflammation, growth factors and proto-oncogenes.80,83-86 Unphosphorylated TTP interacts with
other proteins to bind to the ARE aspect of the mRNA. Binding of TTP to the mRNA induces a
rapid degradation of the mRNA and removal from the cell via exosomes. When TTP is
phosphorylated, the action of TTP is prevented resulting in accumulation of TTP in the
cytoplasm.
TTP is targeted for phosphorylation through MAPK-activated protein kinase-2 (MK2).
This is initially activated by inflammatory stimulants such as LPS. MKK3 and MKK6
phosphorylate the p38 MAPK complex. p38 MAPK activates MK2 through phosphorylation.87 In
turn, MK2 phosphorylates the 52 and 178 serine residues of TTP, which prevents decay of TTP.
MK2 has also shown to increase rapid transcription of TTP, which the authors attribute to the
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kinetic mechanism affecting inflammation.88 A phosphorylated TTP then has affinity for a 14-3-3
chaperone protein, which results in redistribution of TTP from the nucleus to the cytoplasm.
Although there is an increase in the presence of TTP in the cytoplasm, TTP is kept in the inactive
state during an inflammatory response. The resulting effect is increased translation of mRNAs
that were targeted by TTP.89 The importance of MK2 has been shown in MK2 knockout models
with reduced levels of TNF-a, IL-1, IL-6, and IFN-g.90,91 It was also reinforced that MK2 played
a role in the LPS-induced inflammatory process in a mouse study showing a reduction in
osteoclast formation and subsequent decrease in calvarial bone loss. The MK2 knock-out mice
had a significant reduction in inflammation compared to the control.92 The phosphorylation of
TTP is reversed with a protein called protein phosphatase 2A (PP2A), which is a direct
competitor of 14-3-3 for the phosphorylated residues.89 Various studies have shown conflicting
data regarding the deactivation status of TTP and phosphorylation. There are studies that show
that phosphorylation of TTP does not inhibit the ability of TTP to degrade mRNAs.93 On the
other hand, most other studies have concluded that unphosphorylated TTP has a better affinity for
ARE on mRNA than phosphorylated TTP, which allows for increased rate of decay of target
mRNA.94-96
Based upon mice studies, TTP-knockout mice show systemic inflammation with
conditions such as cachexia, erosive arthritis, dermatitis, conjunctivitis, and autoimmunity. TNFa blocking antibodies in TTP-deficient mice showed a cachexia, erosive arthritis, dermatitis,
conjunctivitis, and autoimmunity suggesting that TNF-a mediates a majority of the pathological
changes in response to the loss of TTP in mice.80 Other studies indicate that TTP has an affinity
for mRNA that codes for granulocyte macrophage colony stimulating factor (GM-CSF). GM-CSF
plays a role in immune regulation and activation of macrophages.84 In addition, there was an
increase of IL-6 mRNA stability in TTP knockout mice.94 Genomic studies in TTP knockout mice
identified 23 mRNA transcripts that were stabilized in the absence of TTP. Nine of the 23
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transcripts contained the conserved TTP binding sites.82 TTP was also found to be elevated in
synovial fluids of patients with rheumatoid arthritis.97
Since its discovery in 1990, research on TTP has grown exponentially and knowledge of
TTP, its mechanisms, and targets continues to increase.98 Further research needs to be conducted
to thoroughly understand the systemic effects of TTP. It clearly plays an important role in gene
expression but to what extent is still an area of active investigation.

Tristetraprolin in Periodontitis
In periodontitis, activation of the innate and adaptive immune response can occur in
response to the presence of gram negative bacterial LPS. LPS activates TLRs to initiate a cascade
of events that results in increased expression of multiple inflammatory mediators including IL-1b,
IL-6, IL-17, PGE2, TNF-a, and RANKL. Many cells are involved in the response including
macrophages, dendritic cells, neutrophils, mast cells, osteoblasts, and osteoclasts. The response
results in an imbalance of the homeostasis between pro-inflammatory and anti-inflammatory
modulators. There is an increased transcription of genes coding for inflammatory cytokines
through NF-kb pathways. Additionally, there can be post transcriptional regulation of mRNA
translation by binding of proteins or degradation of mRNAs. The upregulation of inflammatory
cytokines leads to an increase in RANKL and decrease in OPG creating an imbalance in bone
homeostasis. There is an increase in osteoclastogenesis leading to loss of alveolar bone.
As previously discussed, tristetraprolin is a posttranscriptional regulator of mRNAs by
degradation of the transcript. TTP binds the AU-rich elements of specific mRNA strands resulting
in degradation of the mRNA and release from the host cell. TTP has been shown to play a role in
regulation of IL-6, PGE2, and TNFa. TTP was delivered through an adenovirus in vitro. The
findings were that there was a significant reduction in inflammatory cytokines IL-6, PGE2, and
TNFa. In vivo, this study showed that there was a protective effect against inflammation when
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TTP was overexpressed.99 Another indication of TTP’s function in inflammatory regulation is
investigating one of its upstream molecules, p38.100 In the A. actinomycetecomitans LPS-induced
periodontal lesion, there is significant bone loss shown in micro-computed tomography in this rat
model of periodontitis. Inhibition of p38 in the same model significantly reduced the bone
loss.101,102 TNF-a is well-studied and highly linked in the progression of periodontitis. TNF-a is
highly regulated at the level of mRNA stability as manifested in the TTP knockout mice, resulting
in increased stability of TNF-a mRNA.81 These animal studies showed that TTP has an
inflammation suppression effect and support the findings of the function of TTP in a healthy
periodontium. Deactivation of TTP through phosphorylation by MK2 in the presence of an
inflammatory lesion including LPS results in the upregulation of many inflammatory mediators
including the classical proinflammatory cytokines, TNF-a, IL-1b, and IL-6 .

Clinical Implications
Clinicians determine the state of the periodontal tissues and often derive the clinical
diagnosis based upon clinical parameters of disease such as probing depth, clinical attachment
loss, bleeding on probing, plaque index and gingival index. Correlation between molecular and
clinical findings can be problematic since there are many clinical parameters of disease. The
periodontal inflammatory burden index (PIBI) is a method of condensing the clinical
measurements of probing depth to quantify severity of disease on a single tooth. PIBI score is
defined as the number sites with probing depth measurements of 4 or 5mm plus twice the number
of probing depth measurements of greater than or equal to 6mm.19 This score can indicate the
severity of disease and allow for statistical analysis of the data relative to laboratory findings.
Similarly, the clinical attachment loss index (CALI) is measured with the same method but uses
clinical attachment levels rather than probing depths. A positive or negative value can also be
used for bleeding on probing. In a more recent study, MAPK was evaluated compared to scoring
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assigned with PIBI. Immunohistochemistry was used to determine the amount of MAPK present
in tissue samples and were scored. The findings showed that MAPK correlated to higher PIBI
scores indicating that p38-MAPK played a major role in periodontal inflammation.103 These
findings can be clinically important because there can be implications for p38, MAPK, MK2, or
TTP as therapeutic targets to combat inflammation seen in periodontal disease.

Hypothesis and Goals
Based upon on current known mechanisms for TTP and the appreciation that TTP
inactivation by MK2 phosphorylation results in enhanced inflammatory mediator gene expression
and concomitant increased inflammation, we hypothesize that there is an increase in phosphoMK2 and a decrease in active TTP in sites with periodontal disease compared to healthy subjects.
By examining differential kinase expression and activity that directly phosphorylates TTP, as
well as TTP expression itself, the results can provide insight and increase the understanding of the
molecular process of TTP regulation. Human gingival samples classified as healthy or diseased
due to periodontal condition were analyzed with immunohistochemistry (IHC) with the goal to
correlate the levels of MK2, phospho-MK2, and TTP with clinical parameters of periodontal
disease.
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Chapter Two
Materials and Methods
Collection of Human Gingival Samples
This study was approved by the Institutional Review Board of the Medical University of
South Carolina in Charleston, South Carolina. A total of 50 samples were collected from patients
in the Graduate Periodontics clinic at the James B. Edwards College of Dental Medicine at the
Medical University of South Carolina. The patients that were chosen were planned for surgery
and informed on the scope of the research. On the day of the procedure, informed consents were
obtained prior to the planned procedure. Of the 50 patients enrolled, there were 24 females and 26
males. The control group was considered as healthy subjects (n = 25) and the test group included
patients that had periodontal disease (n = 25). All clinical measurements were made on the
sample tooth at the following reference points: mesiobuccal (MB), buccal (B), distobuccal (DB),
mesiolingual (ML), lingual (L), and distolingual (DL). The Plaque Index (PI) for the tooth in
question was recorded. The scoring was a number 0 to 3 and assigned by the following: “0” = no
plaque, “1” = plaque detected clinically with a periodontal probe, “2” = visible deposits of
plaque, “3” = abundant deposits of plaque. Gingival index (GI) was also for the tooth in question.
GI was scored from 0 to 3 where “0” = normal gingiva with no inflammation, “1” = mild
inflammation with slight changes in color and slight edema and no bleeding upon probing, “2” =
moderate inflammation with redness, edema, and bleeding upon probing, “3” = severe
inflammation with marked redness and edema with a tendency to bleed spontaneously.17 Other
clinical measurements included bleeding on probing (BOP), probing depths (PD), gingival
recession (REC), and clinical attachment level (CAL). Patients were included in the control group
if the sample tooth had all of the following parameters at all sites: PD £ 4mm, GI £ 1, PI £ 2, and
lack of BOP. Patients were included in the test group if one of the six reference points had all of
the following parameters: PD > 4mm, GI = 1-3, PI = 1-3, and the presence of BOP. Exclusion
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criteria included patients that were pregnant, smokers, unstable systemic diseases or chronic
disorders (diabetes or rheumatoid arthritis), and use of corticosteroids, NSAID, or other host
modulators in the past 6 months.
Tissues were collected to include sulcular epithelium and the adjacent connective tissue.
For both the control and test groups, tissues were taken from the site that met the above criteria.
Tissues were divided in half chairside. Half the sample was placed in 10% formalin while the
other half was flash frozen and placed in a vial of phosphatase inhibitor (PhosSTOP, Roche
Diagnostics, Germany). The samples placed in 10% formalin were embedded in paraffin and
sectional slides were prepared. Slices of tissue were cut in a fashion that would include a cross
section of epithelium and connective tissue. One out of every ten slides was stained with
hematoxylin and eosin.

Excluded Samples
Upon reviewing histologic slides, patient charts, and radiographs, it was noted that
several samples had potential confounding factors or the sample did not include connective tissue.
One sample #7001 was excluded due to misplacement of the sample. Twenty-seven total samples
were eliminated to confounding factors including caries, crown fracture, vertical root fracture,
and the presence of a sinus tract.
There were several samples (n = 17) that presented with caries in the area where the
sample was obtained. Confirmation of caries was confirmed with analysis of patient charts and
radiographs. The samples that were excluded due to caries included #7002, #7004, #7010, #7011,
#7012, #7024, #7025, #7029, #7030, #7031, #7033, #7036, #7037, #7039, #7040, #7048, and
#7049. There were three samples that had no crown present due to fracture. The samples included
in this exclusion group were #7008, #7026, and #7034. The rationale for excluding these samples
was due to potential lack of ability or altered ability to remove plaque from these areas. Many of
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these samples were included in the healthy subjects which could have resulted in confounding
inflammation. Additionally, sample #7043 was excluded due to the etiologic factor being a
vertical root fracture as opposed to periodontal disease. Sample #7038 presented with a sinus tract
associated with a radiographic periapical lesion. While this lesion may not affect the
periodontium, the exudate expressed from this sinus tract may have been included in the sample
retrieval. Lastly, four samples (#7017, #7018, #7022, and #7050) were excluded due to further
investigation of sample retrieval. The samples were taken from a site remote from the tested
disease site. Therefore, these samples would not coincide with scoring from clinical
measurements resulting in samples that are not relevant. These four samples were excluded from
the test group. Of the remaining samples, only one sample (#7019) did not meet the criteria from
a histology perspective. The sample was too small and did not contain sufficient connective
tissue. Figure 1 depicts the method by which the study sample was determined.
The remaining twenty-two samples were placed in the test group based on the above
criteria regarding PD, PI, GI and BOP. Fifteen samples were placed into the test group while the
remaining samples were placed in the healthy control group.

Periodontal Inflammatory Burden Index (PIBI)
The periodontal inflammatory burden index was calculated according to the protocol
described above.19 For the studied samples, PIBI was calculated based on the number of 4 or
5mm probing depths plus twice the number of probing depths that are 6mm or greater. Score for
PIBI ranged from 0 to 12. Samples taken from implant uncovering (#7003, 7005, 7020) were
assigned probing depths of 1mm although there were no associated probing depths.
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Hematoxylin and Eosin Scoring
An independent pathologist (LZ) scored the H/E slides for inflammatory infiltrate based on the
following parameters: “0” - less than 5% inflammatory infiltrate, “1” - 5% to 25% inflammatory
infiltrate, “2” – Greater than 25% to 50% inflammatory infiltrate, “3” – Greater than 50%
inflammatory infiltrate. The pathologist was blinded to which group each sample belonged.
Reference images of each score were used (Figure 2).

Immunohistochemistry (IHC) Processing
Sectional slides were selected based on proximity to H/E slides. Three paraffin-embedded
slides were selected in sequential order to have comparable IHC sections that were as similar as
possible. Prior to IHC processing, optimization for dilutions of MK2, phospho-MK2 and TTP
antibodies were necessary. Anti-rabbit MK2 antibody (Santa Cruz Biotechnology, Dallas, TX)
was tested at dilutions of 1:75 and 1:100. Analysis of slides showed that 1:100 dilution provided
the adequate staining necessary to score sections. Anti-rabbit phospho-MK2 antibody (Cell
Signaling, Danvers, MA) had a manufacturer recommended dilution of 1:50 for IHC. 1:50 and
1:100 dilutions were tested with the phospho-MK2 antibody and determined that the 1:100
dilution was sufficient for analysis. Anti-rabbit TTP antibody (Genway Biotech, San Diego, CA)
had a manufacturer recommended dilution of 1:200. The tested dilutions for the TTP antibody
were 1:100, 1:200, and 1:400 with 1:400 showing an adequate staining to allow for analysis of the
slides.
Immunohistochemical processing for MK2, phospho-MK2, and TTP for all samples was
performed. Deparaffinized ethanol-dehydrated tissues were placed in heated antigen retrieval
solution that was composed of a citrate buffer. The antigen retrieval solution was at a solution
temperature of 95 degrees Celsius. Slides were incubated in the oven in the antigen retrieval
solution for 20 minutes. It was allowed to cool at room temperature for another 20 minutes.
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Samples were washed three times with 1x PBS solution for five minutes each wash. Control
section and test sections were separated on each slide using a liquid blocking marker. The
samples were incubated at room temperature with Hydrogen Peroxide Block (ThermoFisher
Scientific, Waltham, MA) for 10 minutes. 1x PBS was used to wash the slides. The samples were
incubated with 10% normal goat serum (KPL, Gaithersburg, MD) for 30 minutes at room
temperature. Based on previously mentioned optimization experiments, primary antibodies for
MK2, phospho-MK2, and TTP were diluted accordingly with the Antibody Diluent
(ThermoFisher Scientific, Waltham, MA). Test sections on each slide were incubated with the
primary antibody overnight at 4 degrees Celsius. One section per slide was incubated with the
Antibody Diluent only to serve as a control section. A 1:150 dilution was prepared with the
secondary antibody consisting of biotinylated goat anti-rabbit antibody (Vector Laboratories,
Burlingame, CA). After washing the samples, they were incubated with the secondary antibody
for a total of 1 hour at room temperature. Expression of the secondary antibody was detected
using the Elite ABC reagent (Vectastain, Burlingame, CA) for 30 minutes at room temperature
and DAB substrate (ThermoFisher Scientific, Waltham, MA) for 2 minutes. Contrast staining was
performed with 15% hematoxylin and eosin. Slides were fixed and sealed with Cytoseal 60
(ThermoFisher Scientific, Waltham, MA).

IHC Scoring
An independent oral pathologist (LZ), blinded to the periodontal status of the subjects,
manually completed the IHC scoring. Quantitative immunodetection of MK2, pMK2 and TTP
were scored by use of a semiquantitative analysis.104 Two scoring systems of intensity and area
were used to analyze the IHC staining. The intensity score was obtained by calculation of the
proportion of positively stained target cells with the immunostaining intensity obtained by visual
qualitative observation. Under 40x magnification, the area with highest intensity was identified.
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The intensity score was given as 0 (no staining), 1 (weak staining), 2 (intermediate), and 3
(strong). To assign an area score, five non-coincident microscopic fields at 400x magnification
were consecutively analyzed, 100 cells were counted per field, the total positive cells and
negative cells from 5 fields was summed and percentage was calculated. The area score was
given as 0 (none), 1 (1%–10%), 2 (11%–50%), 3 (51%–80%), and 4 (>80%). Reference slides
were used to score all slides (Figures 3-6). The final composite immunoreactive score was
determined by multiplying the intensity and proportion score of stained cells, with the minimum
score of 0 and maximum score of 12.104,105 Due to high background staining, the epithelium was
not scored. The examiner went through all the slides to identify selected slides that were
representative of each of the four levels of intensity.

Statistical Analysis
All statistical analyses were performed using SAS version 9.4. Spearman rank correlations were
used to assess the relationship between H/E score and the three composite scores, between pMK2
Area % and MK2 Area %, between PIBI and the three composite scores and between H/E and the
three Area Scores. When looking at the relationship between pMK2 Area percentage and MK2
Area percentage, Pearson correlation was used since both variables were continuous. All
correlations were strong and had significant p-values at an alpha level of 0.05, except for the
relationship between PIBI and pMK2 Area Score. Confidence intervals for the correlations were
obtained by back transforming normality-based confidence intervals for the Fisher
transformation106 of the estimated correlation. Because Fisher’s transformation is nonlinear, this
back transformation of the symmetric normality-based confidence interval results in an
asymmetric confidence interval for the raw (untransformed) correlation. A Fisher’s exact test was
also used to look at the relationship between each individual composite score, intensity score and
disease status, as well as H/E and PIBI. When looking to see if there was a difference between
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disease status for Area percentages, Wilcoxon’s signed rank test was used because the outcome
was continuous. All p-values were found to be significant at an alpha level of 0.05.
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Figure 1
The flow chart representation of the selection of the samples. Several patients have confounding
factors that were evaluated radiographically and through patient charts. PD = probing depth, BOP
= bleeding on probing
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Figure 2
Reference slides for Hematoxylin and Eosin inflammatory scoring. Panel A represents a score of
“0” indicating less than 5% inflammatory infiltrate. Panel B represents a score of “1” indicating 5
to 25% inflammatory infiltrate. Panel C represents a score of “2” indicating greater than 25% to
50% inflammatory infiltrate. Panel D represents a score of “3” indicating inflammatory infiltrate
greater than 50%.
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Figure 3
Reference slides for MK2 Area scoring. Five non-coincidental areas were selected and
immunolabeled cells were counted compared to cells that did not show any immunostaining. The
average was taken and a score was assigned. The epithelium was not scored due to high
background staining. Panel A represents an area score of “0” with no immunostaining present.
Panel B represents a score of “1” which indicates 1 to 10% of cells stain positive for the antibody.
Panel C represents a score of “2” which indicates staining 11 to 50% of positive staining cells.
Panel D represents a score of “3” which indicates staining of 51 to 80%. A score of “4” indicates
staining of greater than 80%. However, there were no samples that scored a 4.
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Figure 4
Reference slides for phospho-MK2 Area scoring. Five non-coincidental areas were selected and
immunolabeled cells were counted compared to cells that did not show any immunostaining. The
average was taken and a score was assigned. The epithelium was not scored due to high
background staining. Panel A represents an area score of “0” with no immunostaining present.
Panel B represents a score of “1” which indicates 1 to 10% of cells stain positive for the antibody.
Panel C represents a score of “2” which indicates staining 11 to 50% of positive staining cells.
Panel D represents a score of “3” which indicates staining of 51 to 80%. A score of “4” indicates
staining of greater than 80%. However, there were no samples that scored a 4.

27

A

B

C

D

Figure 5
Reference slides for TTP Area scoring. Five non-coincidental areas were selected and
immunolabeled cells were counted compared to cells that did not show any immunostaining. The
average was taken and a score was assigned. The epithelium was not scored due to high
background staining. Panel A represents an area score of “0” with no immunostaining present.
Panel B represents a score of “1” which indicates 1 to 10% of cells stain positive for the antibody.
Panel C represents a score of “2” which indicates staining 11 to 50% of positive staining cells.
Panel D represents a score of “3” which indicates staining of 51 to 80%. A score of “4” indicates
staining of greater than 80%. However, there were no samples that scored a 4.
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Figure 6
Reference slides for intensity scoring for MK2, pMK2, and TTP. Panels A through D represent
scores of 0 to 3, respectively. The area of the highest intensity was identified under 40x
magnification. A score of “0” indicated no staining. A score of “1” indicated weak staining. A
score of “2” indicated intermediate staining. A score of “3” indicated strong staining.
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Chapter Three
Results
Twenty-two samples of human periodontal tissues were collected from subjects. Nine of
the total samples were obtained from females (41%) and thirteen were obtained from male
subjects (59%). The participants age ranged from 43 to 67 years of age. Racial profiles for the
participants were Caucasian (n = 16, 73%), African American (n = 5, 23%), and Asian (n = 1,
4%). Table 1 displays the distribution and means of the IHC results.
The H&E inflammatory infiltrate was a strong indicator of determining health and
disease. Seven of the studied samples were classified as healthy and fifteen samples were
classified as diseased according to clinical parameters discussed previously. Of the healthy
samples, two (29%) subjects presented with no inflammatory infiltrate (score = 0), four (57%)
showed a mild infiltrate (score = 1), and one (14%) showed severe infiltrate (score = 3). In the
diseased population, two (13%) presented with mild inflammatory infiltrate (score = 1), five
(33%) had a moderate inflammatory infiltrate (score = 2), and eight (54%) had severe
inflammatory infiltrate (score = 3). Figure 7 shows the distribution of inflammatory scores
between health and disease. The mean inflammatory score for health samples was 1.00±1.00 and
for diseased samples was 2.40±0.74. Displayed in Table 2, the Fisher’s exact test showed a
statistically significant relationship between H&E score and periodontal status (p = 0.0055).
The intensity scores for MK2, pMK2 and TTP showed a positive correlation with the
H&E score and PIBI (Table 3, Figure 8). The average MK2 intensity score for healthy samples
was 1.14±0.38 and for diseased samples was 1.93±0.26. pMK2 intensity score averages for health
and disease tissues were 1.14±0.38 and 2.07±0.46, respectively while the average for TTP
intensity scores for health and disease samples were 1.29±0.49 and 2.13±0.64, respectively
(Table 1). The rank correlations for MK2, pMK2, and TTP compared to H&E score were 0.81,
0.81, and 0.84, respectively, and all p-values were less than 0.0001 (Figure 8). Compared to PIBI,
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the rank correlations for the MK2, pMK2, and TTP were 0.67 (p-value = 0.0004), 0.60 (p-value =
0.0028), and 0.60 (p-value = 0.0023), respectively. The six rank correlations values were
statistically significant. The Fisher’s Exact test showed that MK2, pMK2, and TTP intensity
scores showed statistically significant p-values of 0.0006, 0.0007, and 0.2111, respectively.
The area scores also showed a positive correlation with H&E and PIBI scores with the
exception of the pMK2 area score relative to PIBI (Table 3, Figure 8). The average values for the
area scores in health and disease samples for MK2 were 1.29±0.49 and 2.33±0.72, respectively.
pMK2 and TTP area scores for health were 1.57±0.53 and 1.43±0.53, respectively, and for
disease were 2.33±.072 and 2.47±0.64, respectively (Table 1). The results of the Spearman rank
correlation showed statistically significant results for MK2, pMK2, and TTP area scores against
H&E scores with rank correlations of 0.90, 0.78, and 0.91, respectively, with all p-values being
less than 0.0001 (Table 3). Statistically significant results were shown for MK2 and TTP area
scores compared to PIBI with rank correlation values of 0.57 (p-value = 0.0053) and 0.54 (pvalue = .0101), respectively. There was no significant difference in the results of the pMK2 area
score in comparison to PIBI. The rank correlation was 0.42 (p-value = 0.0526). The results of the
Fisher exact test showed high predictability in periodontal status when looking at the MK2 and
TTP area scores (p-value = 0.0157 and 0.0099, respectively). The pMK2 area score was not
statistically significant in predicting periodontal status with a p-value of 0.0641 (Table 2).
Similar to intensity scores, the composite scores for all three proteins showed a positive
correlation to the H&E and PIBI scores and can be predictors of disease (Table 3, Figure 8). The
average composite score for MK2 for health and disease was 1.57±1.13 and 4.60±1.59,
respectively. The pMK2 composite score averages were 1.86±1.07 and 4.93±1.94 for health and
disease, respectively. Lastly, the TTP composite score averages for healthy and diseased samples
were 2.00±1.41 and 5.53±2.59, respectively (Table 1). The rank correlation values of MK2,
pMK2, and TTP composite scores compared to H&E inflammatory scores were 0.93, 0.91, and
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0.91, respectively with all values being highly significant with p-value less than 0.0001 (Table 3).
Statistically significant results were seen in comparing the rank correlations of PIBI to MK2,
pMK2, and TTP composites scores. The rank correlation values were 0.63 (p-value = 0.0017),
0.55 (p-value = 0.0075), and 0.59 (p-value = 0.0038), respectively. Table 2 shows the results of
the Fisher’s Exact Test in predictability of periodontal status given the composite scores of MK2,
pMK2, and TTP. All three values were significant with p-values of 0.0026, 0.0115, and 0.0459,
respectively.
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No. of samples

Distribution of H&E Scores of Health and Disease
9
8
7
6
5
4
3
2
1
0

54%

33%
57%
Healthy
29%

13%
14%

0

1

2

Disease

3

Inflammatory Score
Figure 7
Distribution of healthy and disease samples to H&E Inflammatory score. Percentages of each
group for each inflammatory score are also shown. The samples that were diseased had higher
inflammatory scores. The mean inflammatory score for healthy samples was 1.00 while the mean
for the diseased samples was 2.40.
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Table 1
Distribution of Intensity, Area, and Composite Scores for MK2, pMK2, and TTP

Intensity and Area
MK2 Intensity
MK2 Area
pMK2 Intensity
pMK2 Area
TTP Intensity
TTP Area

Health
Disease
Health
Disease
Health
Disease
Health
Disease
Health
Disease
Health
Disease

Composite
MK2 Composite
pMK2 Composite
TTP Composite

Health
Disease
Health
Disease
Health
Disease

0

1

2

3

Mean

SD

0
0
0
0
0
0
0
0
0
0
0
0

6
1
4
2
6
1
3
2
5
2
4
1

1
14
3
6
1
12
4
6
2
9
3
6

0
0
0
7
0
2
0
7
0
4
0
8

1.14
1.93
1.29
2.33
1.14
2.07
1.57
2.33
1.29
2.13
1.43
2.47

0.38
0.26
0.49
0.72
0.38
0.46
0.53
0.72
0.49
0.64
0.53
0.64

1

2

4

6

9

Mean

SD

4
1
3
1
4
1

2
1
3
1
1
1

1
6
1
5
2
5

0
7
0
7
0
4

0
0
0
1
0
4

1.57
4.60
1.86
4.93
2.00
5.53

1.13
1.59
1.07
1.94
1.41
2.59
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Table 2
Fisher Exact Test showing predictability of periodontal status against protein scoring

Periodontal Status
H&E Score
MK2 Intensity
MK2 Area
MK2 Composite
pMK2 Intensity
pMK2 Area
pMK2 Composite
TTP Intensity
TTP Area
TTP Composite

p-value
0.0055*
0.0006*
0.0157*
0.0026*
0.0007*
0.0641
0.0115*
0.0211*
0.0099*
0.0459*

*Statistically significant results with p-values < 0.05
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Table 3
Spearman Rank Correlations between protein scores with H&E inflammatory score and PIBI

MK2 Intensity
MK2 Area
MK2 Composite
pMK2 Intensity
pMK2 Area
pMK2 Composite
TTP Intensity
TTP Area
TTP Composite

H&E Inflammation Score
Rank Corr.
p-value
0.81
<0.0001*
0.90
<0.0001*
0.93
<0.0001*
0.81
<0.0001*
0.78
<0.0001*
0.91
<0.0001*
0.84
<0.0001*
0.90
<0.0001*
0.91
<0.0001*

Rank Corr.
0.67
0.57
0.63
0.60
0.42
0.55
0.60
0.54
0.59

PIBI†

p-value
0.0004*
0.0053*
0.0017*
0.0028*
0.0526
0.0075*
0.0023*
0.0101*
0.0038*

*Statistically significant results with p-value < 0.05
† PIBI: Periodontal Inflammatory Burden Index: Calculated by the number of PD measurements
of 4 or 5mm plus twice the number of PD measurements x ≥ 6mm.
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Figure 8
Association between H&E scores and PIBI with intensity, area, and composite scores of all
proteins. The Spearman rank correlation and 95% confidence interval are shown.
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Chapter Four
Discussion
In LPS-induced periodontal disease, there is a cascade of events that begins with the
activation of MYD88. The cascade of events involving p38 and MKK3/6 involve the
phosphorylation of MK2. MK2 promotes RNA stability, which allows increased translation of
inflammatory proteins such as IL-1b and TNF-a.88 A major downstream target of MK2 is TTP, a
key RNA binding protein, controlling target gene mediator mRNA expression through mRNA
stability. Phosphorylation of TTP by MK2 stabilizes the protein but inhibits the ability of TTP to
bind to target gene mRNA within the 3’UTR.89 This allows for increased translation of the
cytokines and robust inflammatory response as evidenced in the TTP knockout mice.80 These
mice present with systemic inflammation suggesting that TTP has a more global role rather than a
local effect in periodontitis alone. Indeed, TTP has been linked to oncogenesis, rheumatoid
arthritis, and several other inflammatory-based conditions and diseases.84,86,97 With our
understanding of the pathway from TLR activation to TTP phosphorylation, we wanted to
determine if there are any correlations between MK2, phospho-MK2 and TTP with periodontal
disease progression.
One aspect of this study was to compare the amount of inflammatory infiltrate to the
clinical diagnosis of healthy and diseased periodontal tissues. We confirmed the histologic
findings by Page and Schroeder22 that tissues diagnosed with periodontitis presented with a higher
inflammatory score (2.40±0.74) compared to the healthy samples (1.00±1.00). The standard
deviation was much greater than expected for the healthy samples. One of the seven healthy
samples scored a “3” while the other six samples scored a “0” or “1”. There was no retrospective
data that would explain the higher inflammatory score for the single sample. There were likely
iatrogenic factors that could have contributed to an acute inflammation at the time of sample
retrieval.
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The analysis of the results for MK2 showed that the intensity, area, and composite scores
all positively correlated to the H&E inflammatory scores and PIBI. MK2 levels also were strong
predictors of disease according to the results of the Fisher’s Exact Test. These results are what we
expected due to our understanding of the LPS-induced inflammatory mechanism and agree with
the findings of previous studies. After activation of transmembrane receptor TLR, the p38-MAPK
structure becomes directly involved with MK2. It has been shown that p38-MAPK-MK2
interaction is heavily involved in the induction of cytokine formation.89 In LPS-induced
inflammation, MK2 knock-out mice showed a reduction in inflammation and showed a difference
in macrophage production of cytokines.92 Since p38 is a direct activator of MK2, studies that
show inhibition of p38102 and reduction of inflammation can support our findings on MK2. Using
the MK2 knock-out phenotype, some studies have proven the interaction of MK2 in the
inflammatory pathway. The resulting findings are a decrease in inflammation or cytokines related
with inflammation such as TNF-a and IL-6. In our study, we were able to observe that there was
an increase in expression of MK2 in periodontal disease tissues. The positive correlation of MK2
to inflammation and disease agrees with findings from previous studies.
The data of pMK2 compared to the H&E inflammatory scores showed a significant
positive correlation for all three measurements. However, the comparison to PIBI showed
statistical significance for the intensity and composite score. The pMK2 area score did not show
significance with PIBI as it did for the H&E score, although significance was approached. A
likely explanation for this result of the pMK2 area score and the overall lower correlation could
be how PIBI is measured. PIBI is a cumulative score given based on the circumferential probing
depths of a tooth and increase in severity if a probing depth is 6mm or greater. This could create a
discrepancy due to the possible health of the remaining sites on a tooth. On the other hand, the
H&E score is localized to the area that is inflamed with no obstruction from potentially healthy
sites on the tooth. It has been well documented that MK2 is a direct downstream target of the
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p38-MAPK complex. The p38-MAPK complex activates MK2 in the nucleus by
phosphorylation107,108 which leads to pMK2 transport into the cytoplasm.100 Our results of
increased expression of pMK2 agreed with the findings from other inflammatory models. A study
on luteolin, an herbal anti-inflammatory flavonoid, showed an increased amount of pMK2
compared to the test group that received the luteolin.109 In a oxazolone-induced dermatitis study,
increasing levels of pMK2 were found in a prolonged exposure to oxazolone.110 These studies
analyzed the quantity of pMK2 using a Western blot and the same experimentation should be
used in future studies to analyze human gingival tissues.
Like the MK2 findings, we observed a strong, positive correlation of TTP to both the
H&E inflammatory score and PIBI. In the inflamed tissues, there was increased amount of
staining to the TTP antibody. This is contrary to what has been extensively seen in the literature.
In head and neck cancer, there was increased cancerous invasion and levels of MMP-2, -9 and IL6 with the inactivation of TTP.111 It has been demonstrated that without the function or presence
of TTP, carcinomas progress adversely. Several cancerous models include those of the
breast,112,113 colon,114,115 liver,85,116 cervix,117 and lungs.118 Additionally, TTP shows a similar
correlation in human dendritic cells119 and pulmonary microvascular endothelial cells in chronic
obstructive pulmonary disorders.120 Periodontal disease is an inflammatory condition of the
connective tissue of the periodontium. In mouse models, increased inflammatory activity and
reduced TTP activity is present in stromal tissues, fibroblasts and macrophages.80-82,84 These three
cells types are important components of periodontal disease but the findings from these studies
contrast to those that we found. The increased TTP intensity scoring could be related to the
various forms of TTP present within a cell because it is understood that TTP transcription is
increased with LPS-induced inflammation.121 Unphosphorylated TTP is the activated form and
binds to the untranslated AREs regions of mRNA. Once TTP is phosphorylated by phospho-MK2
at the 52 and 178 serine residues, TTP increases its affinity for the chaperone 14-3-3 molecule.89
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Once bound, 14-3-3 prevents degradation of TTP and places it in the inactive form and remains in
the cytoplasm.95,122 When inflammation is being resolved, the 14-3-3 is replaced with protein
phosphastase 2A (PP2A) which results in dephosphorylation of the serine residues resulting in the
reactivation of TTP’s mRNA decay activity.89,123 The antibody that we used to stain for TTP
binds to the 257-306 residue region. Without any other information, it is reasonable to state that
the TTP-antibody was bound to all forms of TTP and did not discriminate between active and
inactive forms. We are unable to report the amount of each form of TTP present in the human
gingival tissues based on the methods of this study.
A drawback of the area score is that the technique does not take into account the number
of cells present in a given area of interest. In tissues that are affected by periodontal disease, we
expect to see a higher amount of inflammatory infiltrate.22 With inflammation, there is migration
of monocytes, macrophages, lymphocytes, and plasma cells into the affected area. The number of
cells in a given area is greater in an inflamed tissues compared to a healthy one. Therefore, the
samples that showed inflammation would produce a higher number of cells that stain positive for
MK2, pMK2 and TTP. It should be noted that the percentage of reactive inflammatory cells
would be higher in proportion to the normal stromal cells present in connective tissue since the
number of normal cells would be unchanged. This would lead to more cells that are
immunostained in the IHC protocol due to the fact that there is a higher count of inflammatory
cells. In our methods, the area score was a percentage of stained cells to the total number of cells
in the field of view. While this does take into account an increase in the number of cells, it does
not discriminate between an increase between inflammatory cells and normal cells. One way to
potentially normalize the diseased and healthy tissues would be to account for the increase in the
inflammatory cells per area. Another method would be to look at the activity of the normal cells
and filtering the inflammatory cells. TTP is shown to be present in fibroblasts and stromal cells.
Observing the staining of normal cells would remove the factor of the increase in inflammatory
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infiltrate. Likewise staining of individual inflammatory cells such as macrophages can be
compared to the unstained counterparts to assess the activity in a particular cell.
A power analysis had been performed based on previous work on p38 MAPK expression
in periodontal disease.103 However, confounding clinical factors resulted in elimination of
samples from the study. Seventeen of twenty-seven (63%) samples were excluded due to caries. It
has been shown that interproximal caries results in gingival inflammation and bone loss.124 A vast
majority of these samples were placed in the healthy group, which would have resulted in a false
display of inflammation in a clinically healthy tissue sample. Our final sample size of twenty-two
was small, so a Fisher’s Exact test was necessary instead of an ANOVA test. The results of the
Fisher Exact Test (Table 1) show that all measurements aside from the area score of pMK2 can
have a high predictability on determining health or disease. This information supports that the
expression of MK2, pMK2, and TTP are increased in the presence of periodontal disease.
However, the data from this study alone cannot confirm the mechanistic pathway from p38
phosphorylation to TTP deactivation.
We believe it is important to understand which forms of TTP are present in periodontal
health and disease. It is important to determine the amount of TTP that is in the inactivated state,
which can provide insight into the kinetics of TTP deactivation and reactivation. Coimmunoprecipitation could be used to isolate the inactivated TTP by selection of the 14-3-3
protein. A Western blot could then be used to probe for the TTP and the quantity can be
compared to the isolation of unbound TTP alone. A proportion could be formed to compare the
differences in health and disease, so we can have a better understanding of the extent of TTP
deactivation during periodontal disease. Another possible way to determine how much TTP has
been phosphorylated is to do immunohistochemistry with a phospho-TTP antibody and compare
it to the TTP staining. Quantification of TTP is an important piece of information that was not
provided in our study.
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There were several weaknesses to this study. As it was mentioned previously, the number
of samples that were used for the study did not meet the power that was determined by the power
analysis. We tested seven healthy samples and fifteen diseased samples as opposed to twenty-five
in each group. Perhaps, the results would be more impactful had the quantity of samples been
greater. We also did not normalize the data to account for an increase in inflammatory infiltrate
for the area scoring. Our results showed a strong, positive correlation between the H&E
inflammatory scores compared to the area scores for all three proteins. This was likely an
imbalanced analysis that was heavily skewed due to the levels of inflammatory infiltrate. The
intensity score also only provided a qualitative analysis based on how dark the cells stained so
scoring is at the discretion of the pathologist’s subjectivity. Therefore, we cannot report any
quantitative data regarding expression of MK2, pMK2, and TTP.
Although we were unable to provide any quantitative data, we were able to make
generalized correlations between the expressions of each protein and the amount of inflammation
and clinical parameters. This supports findings from previous studies that the p38-MAPK-MK2
pathway is activated in the inflammatory process of periodontal disease. However, our results on
TTP contrast from the extensive literature that is explained by the non-discriminatory binding of
the TTP antibody to active and inactive TTP forms. There is a need for focused attention on the
TTP deactivation process in inflammation as well as the impact of TTP on the overall periodontal
inflammatory response to a bacterial insult. With a better understanding of TTP, it may become a
therapeutic target in treatment of periodontal disease.
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